A Study to Compare the Efficacy and Safety of Intravitreal APL-2 Therapy With Sham Injections in Patients With Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration
Condition(s):Geographic AtrophyLast Updated:July 6, 2023Completed
Hide Studies Not Open or Pending
Condition(s):Geographic AtrophyLast Updated:July 6, 2023Completed
Condition(s):Macular Edema; Retinal Vein OcclusionLast Updated:May 10, 2017Completed
Condition(s):Diabetes Mellitus; Macular EdemaLast Updated:April 17, 2017Completed
Condition(s):Diabetes Mellitus; Macular EdemaLast Updated:April 17, 2017Completed
Condition(s):Choroid Neovascularization Secondary to Degenerative MyopiaLast Updated:June 4, 2014Unknown status
Condition(s):Posterior Uveitis; Intermediate Uveitis; PanuveitisLast Updated:July 21, 2020Completed
Condition(s):Glaucoma, NeovascularLast Updated:September 15, 2017Completed
Condition(s):Geographic AtrophyLast Updated:September 25, 2019Completed
Condition(s):Symptomatic Irreversible PulpitisLast Updated:January 15, 2019Completed
Condition(s):Leber’s Hereditary Optic Neuropathy (LHON)Last Updated:November 14, 2022Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.